A VIB Tools & Technologies conference

After two successful editions (organized in June 2015 & October 2017) featuring each time ~300 attendees, we are pleased to announce the 3^rdedition that will take place in December 2019.

The ‘Next-Generation Protein Analysis and Detection’ conference will bring together top scientists from Academia and Companies with novel technologies in several sessions.

New as well as recurring topics will be discussed:

• Analytical and Clinical Proteomics
• Protein Interaction Analysis & Design
• Single Cell and Single Protein Analysis
• Recombinant Antibody tools
• Interactomics
• Bio-sensing and molecular interactions
• …

Since 2013, our institute, VIB, has set up a series of “Tools and Technologies” meetings focused on fast-moving life sciences technology fields. Those meetings focus on the front end of innovation and bring together key innovators in selected life sciences research fields

In addition to great scientific and technology program, the conference will provide ample networking opportunities during the breaks and conference dinner.

Poster information:

Format: A0 (841 x 1189 mm / 33.1 x 46.8 in), portrait orientation

Website link: https://vibconferences.be/event/next-generation-protein-analysis-and-detection-3rd-edition

Address:
UGent – Aula Universiteit Gent
Voldersstraat 9
9000 Gent

Deadlines:

• Abstract submission: 30 September 2019
• Early bird registration: 21 October 2019
• Late Reg deadline: 18 November 2019

 

Speakers:

• Yifat Merbl – Weizmann Institute of Science, IL
• Matthias Mann – Max Planck Institute of Biochemistry, DE
• Bernd Wollscheid – ETH Zürich, CH
• Rachel Amouroux – Head of Research, Inoviem Scientific, FR
• Ulf Landgren – Uppsala University, SE
• Karen Vanhoorelbeke – KU Leuven, BE
• Andrew Emili – Boston University School of Medicine, US
• Andrew Heron – Director of Advanced Research – Oxford Nanopore Technologies Ltd, UK
• Chirlmin Joo – Kavli Institute of Nanoscience Delft, NL
• David Juncker – McGill University & Genome Quebec Innovation Centre, CA
• Markku Varjosalo – University of Helsinki, FI
• Christoph Merten – EMBL, Genome Biology Unit, Heidelberg, DE
• Bernhard Suter – CEO, Next Interactions, US
• Jeffrey Zonderman – CCO, RedShift Bioanalytics , US
• Sai Reddy – ETH Zurich, CH
• Talli Somekh – CEO & Cofounder, Erisyon, US
• Kathryn Lilley – University of Cambridge, UK
• Philipp Kukura – University of Oxford, UK
• Andrea Sinz – Martin-Luther University Halle-Wittenberg, DE
• Nick Devoogdt – Co-founder and Scientific Advisor, Camel-IDS, BE
• Simone Lemeer – University Utrecht, NL
• Joshua B. Edel – Imperial College London, UK
• Andreas Schmidt – CEO, Proteona, US
• Michael Weiner – V.P. Molecular Sciences Abcam, US
• Milad Dagher – Co-founder and CEO, nplex biosciences, CA
• Rob Beynon – University of Liverpool, UK